HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

FEATURED

2018 ▼
2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Lupin appoints Indrajit Banerjee as President – Finance and Planning

December 16, 2004

Lupin receives IND approvals for anti-TB and anti-psoriasis molecules

December 2, 2004

Lupin cranks up the R&D Engine

October 27, 2004

Lupin triples Research spend

July 29, 2004

Lupin and Ind-Swift launch new anti-diarrhoeal drug

June 9, 2004

Lupin FY 2003-04 revenue up 22% at Rs 12.3 bn

April 28, 2004

Lupin receives INDA approval for psoriasis oral treatment

April 22, 2004

Lupin Launches Branded Finished Dosage in the US Sets up Pediatric Sales Force

April 6, 2004

Lupin Enters into Collaboration to Promote Zymar to Pediatricians in the U.S.

March 29, 2004

Lupin unveils herbal products.

March 23, 2004

Lupin Launches Herbal Business

March 2004

Lupin enters into an alliance with Baxter for Ceftriaxone

February 28, 2004

Lupin receives USFDA approval for Cefixime Suspension

February 24, 2004

Lupin receives USFDA approval for Cefixime Tablets

February 13, 2004

Lupin Net Profit up 77% at Rs. 400 mn; Net Sales up 10% at Rs. 2629 mn;Debt Equity Ratio improves to 0.85:1

January 20, 2004

Lupin appoints new President for Asia Pacific,Latin America

January 8, 2004

Lupin launches novel cholesterol-fighter EZEDOC

January 2, 2004